Business Context and Reporting Period
Company: Equity Bancshares, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 23, 2020
Reporting Period: Event date October 22, 2020
The filing announces regulatory approval for a new share repurchase program following the completion of a prior program.
Key Financial Metrics
This filing does not report current period revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on capital allocation activities.
| Metric | Value |
|---|---|
| Prior Repurchase Program (2019) Shares | 1.1 million |
| Prior Repurchase Program Total Cost | $23.7 million |
| Prior Repurchase Program Average Price | $21.54 per share |
| New Repurchase Authorization | Up to 800,000 shares |
Material Changes
The primary material change is the authorization of a new share repurchase program effective October 30, 2020, concluding October 29, 2021. This follows the successful completion of the 2019 program.
Guidance, Outlook, and Management Commentary
- Regulatory Approval: The Federal Reserve Bank of Kansas City advised the Company on October 22, 2020, that it had no objection to the new repurchase authorization.
- Execution Method: Shares may be repurchased via privately negotiated transactions, open market purchases, or Rule 10b5-1 trading plans.
- Flexibility: The program does not obligate the Company to acquire a specific dollar amount or number of shares. It may be extended, modified, or discontinued at any time without notice.
- Risks/Contingencies: The filing notes standard compliance with federal securities laws but does not disclose specific new risks or contingencies beyond the discretionary nature of the buyback.
Investor Verification Checklist
- Verify the exact start date of the new repurchase program (October 30, 2020).
- Confirm the total number of shares authorized for repurchase (800,000).
- Review the terms of the completed 2019 program to understand historical buyback behavior.
- Monitor future filings for actual execution of the new program, as the Company is not obligated to purchase the full authorized amount.